PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Publication | Open Access

DOI Full Paper Access

171

Citations

References

2014

Year

Ralph Zinner, Coleman K. Obasaju, David R. Spigel, Robert Weaver, J. Thaddeus Beck, David Waterhouse, Manuel Modiano, Borys Hrinczenko, Petros Nikolinakos, Jingyi Liu,

Journal of Thoracic Oncology